Merck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The company beat expectations with revenues of US$16b arriving 3.8% ahead of forecasts. Statutory earnings per share (EPS) were US$1.87, 4.4% ahead of estimates. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
View our latest analysis for Merck
Taking into account the latest results, the consensus forecast from Merck’s 25 analysts is for revenues of US$64.0b in 2024. This reflects an okay 4.3% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to jump 751% to US$7.75. Yet prior to the latest earnings, the…
